These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 6189392)
41. Clinical features of HBsAg-negative but anti-HBc-positive hepatocellular carcinoma in a hepatitis B virus endemic area. Shim J; Kim BH; Kim NH; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R J Gastroenterol Hepatol; 2005 May; 20(5):746-51. PubMed ID: 15853989 [TBL] [Abstract][Full Text] [Related]
42. Relationship of hepatitis B antigen in cirrhosis and hepatoma in Thailand. An etiological significance. Chanuvati T; Viranuvatti V; Pongpipat D Gastroenterology; 1975 May; 68(5 Pt 1):1261-4. PubMed ID: 47828 [TBL] [Abstract][Full Text] [Related]
43. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection. Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507 [TBL] [Abstract][Full Text] [Related]
44. Pathobiology of hepatitis B virus. Gerber MA; Thung SN Pathobiol Annu; 1981; 11():197-228. PubMed ID: 6276845 [No Abstract] [Full Text] [Related]
45. [Expression of GST-pi and HBV infection in hepatocellular carcinoma]. Shen LJ; Zhang ZJ; Zhang HX; Yang WB; Huang R Ai Zheng; 2002 Jan; 21(1):29-32. PubMed ID: 12500393 [TBL] [Abstract][Full Text] [Related]
46. Tissue markers of hepatitis B virus infection in hepatocellular carcinoma and cirrhosis. Craxi A; Pasqua P; Giannuoli G; Di Stefano R; Simonetti RG; Pagliaro L Hepatogastroenterology; 1984 Apr; 31(2):55-9. PubMed ID: 6327478 [TBL] [Abstract][Full Text] [Related]
47. Hepatitis B virus infection predicts extrahepatic metastasis after hepatic resection in patients with large hepatocellular carcinoma. Sasaki A; Kai S; Endo Y; Iwaki K; Uchida H; Shibata K; Ohta M; Kitano S Ann Surg Oncol; 2007 Nov; 14(11):3181-7. PubMed ID: 17846843 [TBL] [Abstract][Full Text] [Related]
48. [The vaccine for hepatitis B virus. Definition of criteria for its use]. Sturm JA Rev Paul Med; 1985; 103(1):23-31. PubMed ID: 2994199 [No Abstract] [Full Text] [Related]
49. Clinical course and survival after liver transplantation for hepatitis B virus infection complicated by hepatocellular carcinoma. Wong PY; McPeake JR; Portmann B; Tan KC; Naoumov NV; Williams R Am J Gastroenterol; 1995 Jan; 90(1):29-34. PubMed ID: 7801944 [TBL] [Abstract][Full Text] [Related]
50. Hepatocellular carcinoma after non-A, non-B posttransfusion hepatitis. Kiyosawa K; Akahane Y; Nagata A; Furuta S Am J Gastroenterol; 1984 Oct; 79(10):777-81. PubMed ID: 6091443 [TBL] [Abstract][Full Text] [Related]
52. T1653 mutation in the box alpha increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C infection. Ito K; Tanaka Y; Orito E; Sugiyama M; Fujiwara K; Sugauchi F; Kato T; Tokita H; Izumi N; Kato M; Yuen MF; Lai CL; Gish RG; Ueda R; Mizokami M Clin Infect Dis; 2006 Jan; 42(1):1-7. PubMed ID: 16323084 [TBL] [Abstract][Full Text] [Related]
53. Hepatitis B antigen, alpha-fetoglobulins and primary hepatocellular carcinoma in Ethiopia. Tsega E; Gold P; Shuster J; Whittemore B; Lester FT J Trop Med Hyg; 1976 Oct; 79(10):230-4. PubMed ID: 64619 [No Abstract] [Full Text] [Related]
54. Hepatitis B surface antigen and alpha-1-fetoprotein in hepatoma. Reports of 157 cases. Pongpipat D; Suvatte V; Plengvanit U; Chinapak O; Bunyaphisit S; Assateerawatts A J Med Assoc Thai; 1983 Nov; 66(11):696-9. PubMed ID: 6200559 [No Abstract] [Full Text] [Related]
55. [Serum hepatitis B antigen-antibody system in patients with hepatocellular carcinoma]. Wu A; Cheng G Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):441-3. PubMed ID: 8697998 [TBL] [Abstract][Full Text] [Related]
56. [Significance of genetic technics for the diagnosis and prevention of hepatitis B virus infections]. Gerlich WH Internist (Berl); 1985 Feb; 26(2):63-7. PubMed ID: 2984133 [No Abstract] [Full Text] [Related]
57. Clinical characteristics and surgical outcome in hepatocellular carcinoma without hepatitis B virus surface antigen or hepatitis C virus antibody. Tanaka K; Shimada H; Matsuo K; Nagano Y; Endo I; Togo S Ann Surg Oncol; 2007 Mar; 14(3):1170-81. PubMed ID: 17195904 [TBL] [Abstract][Full Text] [Related]
58. [Hepatitis B virus infection: current developments]. van Ditzhuysen JM; van Loon AM; Yap SH Ned Tijdschr Geneeskd; 1983 Nov; 127(48):2193-8. PubMed ID: 6318129 [No Abstract] [Full Text] [Related]
59. Hepatitis B virus subtypes and hepatitis C virus genotypes in patients with chronic liver disease in Nepal. Shrestha SM; Tsuda F; Okamoto H; Tokita H; Horikita M; Tanaka T; Miyakawa Y; Mayumi M Hepatology; 1994 Apr; 19(4):805-9. PubMed ID: 8138250 [TBL] [Abstract][Full Text] [Related]
60. Hepatitis G virus infection in patients with hepatocellular carcinoma in Recife, Brazil. Leão-Filho GC; Lopes EP; Ferraz AA; Moura I; Pernambuco JR; Reis C; Silva AE; Ferraz ML Jpn J Clin Oncol; 2007 Aug; 37(8):632-6. PubMed ID: 17704535 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]